aripiprazole has been researched along with d-alpha tocopherol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Le, J; Li, Y; Wang, S; Yuan, T | 1 |
| Choudhury, H; Gorain, B; Kokare, CR; Kumbhar, SA; Shrivastava, B | 1 |
1 review(s) available for aripiprazole and d-alpha tocopherol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for aripiprazole and d-alpha tocopherol
| Article | Year |
|---|---|
Effects of Atypical Antipsychotics on Neuroactive Vitamins in Patients With Schizophrenia.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Case-Control Studies; Female; Humans; Male; Olanzapine; Paliperidone Palmitate; Schizophrenia; Vitamin A; Vitamin D; Vitamin E; Vitamins; Young Adult | 2020 |
Antipsychotic Potential and Safety Profile of TPGS-Based Mucoadhesive Aripiprazole Nanoemulsion: Development and Optimization for Nose-To-Brain Delivery.
Topics: Administration, Intranasal; Animals; Antipsychotic Agents; Aripiprazole; Brain; Drug Delivery Systems; Emulsions; Nanoparticles; Nasal Mucosa; Rats; Rats, Wistar; Sheep; Vitamin E | 2021 |